CIK: 0001582844 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $135,742 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 290,500 | $19,161 | 14.1% | $43.69 | +32.1% | COM | 03753U106 |
| WHWK | AADI BIOSCIENCES INC | 1,849,402 | $13,390 | 9.9% | $27.48 | -61.1% | COM | 00032Q104 |
| TERN | TERNS PHARMACEUTICALS INC | 1,099,309 | $13,016 | 9.6% | $5.72 | +67.1% | COM | 880881107 |
| — | CYMABAY THERAPEUTICS INC. COMMON STOCK | 878,500 | $7,661 | 5.6% | $6.27 | — | COM | 23257D103 |
| VTYX | VENTYX BIOSCIENCES INC | 208,500 | $6,985 | 5.1% | $21.58 | +80.2% | COM | 92332V107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 330,000 | $6,970 | 5.1% | $19.65 | +26.6% | COM | 87164F105 |
| KURA | KURA ONCOLOGY INC. COMMON STOCK | 565,257 | $6,913 | 5.1% | $14.74 | -15.4% | COM | 50127T109 |
| — | IVERIC BIO INC | 280,500 | $6,825 | 5.0% | $7.63 | — | COM | 46583P102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 23,500 | $5,263 | 3.9% | $220.39 | +11.9% | COM | 91307C102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 298,000 | $5,105 | 3.8% | $18.56 | +5.5% | COM | 77313F106 |
| — | BELLUS HEALTH INC | 632,500 | $4,554 | 3.4% | $8.20 | — | COM NEW | 07987C204 |
| SRPT | SAREPTA TEHRAPEUTICS INC | 32,770 | $4,517 | 3.3% | $106.61 | +21.7% | COM | 803607100 |
| PCVX | VAXCYTE INC | 120,500 | $4,516 | 3.3% | $31.07 | +36.5% | COM | 92243G108 |
| CLDX | CELLDEX THERAPEUTICS INC | 121,500 | $4,372 | 3.2% | $9.46 | +356.0% | COM NEW | 15117B202 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 168,000 | $4,274 | 3.1% | $17.88 | +79.3% | COM | 92790C104 |
| — | IVERIC BIO INC | 1,500 | $3,650 | 2.7% | — | — | Call | 99D2WLPZ9 |
| — | CELLDEX THERAPEUTICS INC | 1,000 | $3,598 | 2.7% | — | — | Put | 99D2DH6V9 |
| ARGX | ARGEN SE | 9,594 | $3,575 | 2.6% | $375.90 | — | SPONSORED ADR | 04016X101 |
| GHRS | GH RESEARCH PLC | 243,250 | $1,944 | 1.4% | $20.48 | -55.1% | ORDINARY SHARES | G3855L106 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 104,753 | $1,801 | 1.3% | $19.45 | 0.0% | COM | 35104E100 |
| ACRS | ACLARIS THERAPEUTICS | 121,840 | $986 | 0.7% | $16.22 | -21.8% | COM | 00461U105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 153,639 | $939 | 0.7% | $19.89 | -65.3% | COM | 462260100 |
| ALKS | ALKERMES PLC | 31,689 | $893 | 0.7% | $27.24 | 0.0% | SHS | G01767105 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 303,396 | $892 | 0.7% | $11.19 | -68.1% | COM NEW | 30233G209 |
| PMVP | PMV PHARMACEUTICALS INC | 154,471 | $737 | 0.5% | $17.26 | -59.2% | COM | 69353Y103 |
| RZLT | REZOLUTE INC | 366,204 | $703 | 0.5% | $3.32 | -32.3% | COM NEW | 76200L309 |
| ELVN | ENLIVEN THERAPEUTICS INC | 30,979 | $678 | 0.5% | $20.34 | 0.0% | COM | 29337E102 |
| — | HORIZON THERAPEUTICS PLC | 6,000 | $655 | 0.5% | $106.80 | — | SHS | G46188101 |
| SVRA | SAVARA INC | 199,031 | $388 | 0.3% | $2.25 | 0.0% | COM | 805111101 |
| — | MERSANA THERAPEUTICS INC | 60,000 | $247 | 0.2% | $5.86 | — | COM | 59045L106 |
| VKTX | VIKING THERAPEUTICS INC | 14,000 | $233 | 0.2% | $10.33 | 0.0% | COM | 92686J106 |
| KROS | KEROS THERAPEUTICS INC | 3,575 | $153 | 0.1% | $46.71 | +8.1% | COM | 492327101 |
| — | HILLEVAX INC | 6,664 | $110 | 0.1% | $16.53 | — | COM | 43157M102 |
| — | KINNATE BIOPHARMA INC | 5,000 | $31 | 0.0% | $12.00 | — | COM | 49705R105 |
| — | NUVATION BIO INC | 90,832 | $11 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |